A detailed history of Cap Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cap Wealth Advisors, LLC holds 1,262 shares of ABBV stock, worth $227,160. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,262
Previous 1,170 7.86%
Holding current value
$227,160
Previous $200,000 24.5%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$163.84 - $199.33 $15,073 - $18,338
92 Added 7.86%
1,262 $249,000
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $154 - $180
1 Added 0.09%
1,170 $200,000
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $264,981 - $301,921
-1,658 Reduced 58.65%
1,169 $212,000
Q4 2023

Jan 31, 2024

BUY
$137.6 - $154.97 $39,078 - $44,011
284 Added 11.17%
2,827 $438,000
Q3 2023

Nov 01, 2023

SELL
$133.59 - $154.65 $45,420 - $52,581
-340 Reduced 11.79%
2,543 $379,000
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $7,950 - $9,894
-60 Reduced 2.04%
2,883 $388,000
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $14,316 - $16,487
-99 Reduced 3.25%
2,943 $469,000
Q4 2022

Feb 01, 2023

BUY
$138.31 - $165.87 $55,324 - $66,348
400 Added 15.14%
3,042 $491,000
Q3 2022

Nov 02, 2022

SELL
$134.21 - $153.93 $41,336 - $47,410
-308 Reduced 10.44%
2,642 $355,000
Q2 2022

Aug 05, 2022

BUY
$137.62 - $174.96 $38,946 - $49,513
283 Added 10.61%
2,950 $452,000
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $351,990 - $436,721
-2,667 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $286,515 - $362,525
2,667 New
2,667 $361,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cap Wealth Advisors, LLC Portfolio

Follow Cap Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cap Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cap Wealth Advisors, LLC with notifications on news.